zoledronate

(redirected from Reclast)
Also found in: Dictionary.
Related to Reclast: Zoledronic acid

zoledronate

Zoledronic acid, Zometa® Osteoporosis A potent bisphosphonate used to ↓ fractures, ↓ bone pain Indications Postmenopausal osteoporosis, CA metastases to bone Adverse events Myalgia, pyrexia. See Biphosphonate, Osteoporosis.
Mentioned in ?
References in periodicals archive ?
The company added that Zoledronic Acid Injectionin the 5 mg/100 mL Single Dose Vial is the generic version of Novartis' Reclast Injection.
And recently approved Reclast is a single infusion that prevents postmenopausal osteoporosis for two years or treats osteoporosis for a year.
This forecast assesses the impact of generics, especially upon patent expiry of key bisphosphonate drugs such as Actonel, Boniva, and Reclast.
But bisphosphonates -- such as Merck's Fosamax, Roche's Boniva, Novartis's Reclast, and Warner Chilcott's Actonel -- remain the most popular option, and can be bought for as little as $10 per month in the US.
review, published in The New England Journal of Medicine online recently, was prompted by a growing debate over how long women should continue using the drugs, known as bisphosphonates, which are sold as generic versions of brands like Fosamax and Boniva, as well as Novartis's Reclast.
Similarly, the dosage with which a drug is administrated, can uncover the patient's condition, for example, the drug Reclast is usually used in lower doses to prevent osteoporosis but is used in higher doses to treat bone cancer.
The NWHN will use all the advocacy tools at its disposal to press the FDA to make changes in how drug companies are allowed to market bisphosphonates like Fosamax, Actonel, Boniva and Reclast (as well as the many generic bisphosphonates) to healthy women.
The drugs affected are Actonel; Actonel Plus Calcium; Atelvia; Boniva; Fosamax; Fosamax Plus D; and Reclast, as well as their generic offspring.
Zometa, given as an infusion, also is sold at a lower dose under the name Reclast or Aclasta to treat osteoporosis.
which manufactures the bisphosphonate Reclast (zoledronic acid).
More serious cases of bone loss warrant more serious treatments, such as the annual infusion with Reclast like Ms.